HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
LQDA
Liquidia Corp
Healthcare Biotechnology · North Carolina, USA · Reports in usd
Market Cap: $3.68B
Market Cap
$3.68B
Enterprise Val
$3.68B
P/E Ratio
-53.39
P/B Ratio
82.24
Trailing PEG (1Y)
0.39
As Of
May 7, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$44.7M
Gross Margin92.33%
Profit Margin92.33%
Return on Equity-209.33%
Return on Assets-25.32%
Current Ratio2.01
Debt/Equity4.42
LT Debt/Equity3.11
Revenue Per Share1.06

Income Statement

Dec 31, 2025
Revenue$92.0M
Cost of Revenue$7.1M
Gross Profit$85.0M
R&D$16.9M
SG&A$48.2M
Operating Expenses$65.2M
Operating Income$19.8M
Interest Expense$6.9M
Tax Expense$0.00
Net Income$14.6M
EPS (Basic)$0.17
EPS (Diluted)$0.17
EBIT$21.5M
EBITDA$21.8M
Consolidated Income$14.6M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$194.2M
Accounts Receivable$54.1M
Inventory$23.8M
Current Assets$273.4M
LT Investments$0.00
Property, Plant & Equipment$15.8M
Intangibles$6.9M
Non-Current Assets$54.5M
Total Assets$327.9M
Accounts Payable$3.7M
Current Debt$58.9M
Current Liabilities$135.8M
LT Debt$139.0M
Non-Current Liabilities$147.4M
Total Liabilities$283.2M
Total Debt$197.9M
Retained Earnings-$626.3M
Shareholder Equity$44.7M
Shares Outstanding86,995,483

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$44.2M
Investing Cash Flow-$4.0M
Financing Cash Flow-$7.0M
CapEx-$2.0M
Free Cash Flow$42.2M
Depreciation & Amort.$385.0K
Stock-Based Comp$7.2M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid-$8.1M
Equity Issued/Repaid$935.0K
Dividends Paid$0.00
Net Change in Cash$33.2M
Data cached · Meta live · Daily live · Statements live · TTL 24h